Arctoris expands senior team

Arctoris strengthens senior team to continue the development of its on-demand drug discovery services​. Joining Arctoris in senior roles are Professor John Mattick, Member of the Board of Directors (left) & Dr Daniel Thomas, Head of Discovery Biology (right) OXFORD, UK – 13 November 2019 Arctoris Ltd today announced the appointment of Professor John Mattick AO FAA […]

Arctoris opens new facility

Arctoris successfully moves into its new global headquarters in Oxford, UK​ OXFORD, UK – 11 December 2019 Arctoris Ltd, the developer of the world’s first fully automated drug discovery platform, today opened the doors to its new global headquarters and state-of-the-art research and development (R&D) facility in Oxford, UK. Housing the company’s proprietary technology and […]

BioTarget 2020 launch

Arctoris launches BioTarget 2020 competition to support innovation in emerging biotech companies OXFORD, UK – 21 February, 2020 Arctoris Ltd has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs. BioTarget 2020 is now open for applications. BioTarget is a non-profit initiative, sponsored by Arctoris Ltd and leading investment management firm Baillie […]

Molecule Partnership

Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development OXFORD, UK – 10th February 2020 Arctoris Ltd has announced a formal partnership with Molecule in order to tackle the ongoing innovation crisis faced by drug discovery and development across both industry and academia. Through its fully automated drug discovery platform, Arctoris […]